Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Pemigatinib is used in adults to treat bile duct cancer that has spread to other···【more】
Release date：2024-08-14Recommended：280
Selpercatinib is a targeted drug for the treatment of RET gene mutations, which ···【more】
Release date：2024-08-14Recommended：249
Venetoclax reduces the viability of cancer cells by highly selectively inhibitin···【more】
Release date：2024-08-14Recommended：210
Venetoclax is a novel BCL-2 inhibitor that induces apoptosis in cancer cells by ···【more】
Release date：2024-08-14Recommended：239
Venetoclax is the world's only approved selective inhibitor of Bcl-2 that ca···【more】
Release date：2024-08-14Recommended：253
Venetoclax restores normal apoptosis of cancer cells by blocking the anti-apopto···【more】
Release date：2024-08-14Recommended：288
Venetoclax is the only approved inhibitor of Bcl-2, which achieves high selectiv···【more】
Release date：2024-08-14Recommended：250
Venetoclax is an oral, small-molecule targeted drug that restores the apoptosis ···【more】
Release date：2024-08-14Recommended：283
Venetoclax is the world's first approved selective inhibitor of Bcl-2 that i···【more】
Release date：2024-08-14Recommended：301
Pemigatinib is a targeted therapy drug that is of great significance in the trea···【more】
Release date：2024-08-14Recommended：262
Pemigatinibis primarily used for the treatment of adult patients with advanced, ···【more】
Release date：2024-08-14Recommended：246
Pemigatinibhas demonstrated significant efficacy in the treatment of cholangioca···【more】
Release date：2024-08-14Recommended：280
